O van Tellingen - JoVE Visualize

Showing results (91-100 of 100) with videos related to

Pageof 10

Sort By:

You have reached the last page of results.This site can display upto 100 results.

Journal of Chromatography. B, Biomedical Sciences and Applications|July 20, 1999

Bioanalysis of aplidine, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography after derivatization with trans-4-hydrazino-2-stilbazoleR W Sparidans, J J Kettenes-van den Bosch, O van Tellingen, et al.

Journal of Chromatography. B, Biomedical Applications|May 19, 1995

Analytical procedure for the determination of the new antitumour drug N-benzoylstaurosporine and three potential metabolites in human plasma by reversed-phase high-performance liquid chromatographyR van Gijn, O van Tellingen, J J de Clippeleir, et al.

British Journal of Cancer|November 27, 2001

The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patientsM M Malingré, J H Schellens, O Van Tellingen, et al.

Neuro-Oncology|June 16, 2025

Cranial radiotherapy profoundly affects glia without inducing widespread cellular senescenceL E Kuil, R H van Scheppingen, Y M Leter, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1991

Phase I study of vintriptol, a tryptophan ester of vinblastineH M Oosterkamp, L T Vlasveld, J Wanders, et al.

Anti-Cancer Drugs|December 29, 2000

Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol) and carboplatin in non-small cell lung cancer patientsJ Meerum Terwogt, O van Tellingen, V R Nannan Panday, et al.

European Journal of Cancer (Oxford, England : 1990)|June 13, 1998

Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell linesP J van de Vaart, N van der Vange, F A Zoetmulder, et al.

Cell|May 20, 1994

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsA H Schinkel, J J Smit, O van Tellingen, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteinsA H Schinkel, U Mayer, E Wagenaar, et al.

The Journal of Pharmacology and Experimental Therapeutics|April 14, 2006

Carcinogen and anticancer drug transport by Mrp2 in vivo: studies using Mrp2 (Abcc2) knockout miceM L H Vlaming, K Mohrmann, E Wagenaar, et al.

Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:

Pageof 10

You have reached the last page of results.This site can display upto 100 results.

Journal of Chromatography. B, Biomedical Sciences and Applications|July 20, 1999

Bioanalysis of aplidine, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography after derivatization with trans-4-hydrazino-2-stilbazoleR W Sparidans, J J Kettenes-van den Bosch, O van Tellingen, et al.

Journal of Chromatography. B, Biomedical Applications|May 19, 1995

Analytical procedure for the determination of the new antitumour drug N-benzoylstaurosporine and three potential metabolites in human plasma by reversed-phase high-performance liquid chromatographyR van Gijn, O van Tellingen, J J de Clippeleir, et al.

British Journal of Cancer|November 27, 2001

The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patientsM M Malingré, J H Schellens, O Van Tellingen, et al.

Neuro-Oncology|June 16, 2025

Cranial radiotherapy profoundly affects glia without inducing widespread cellular senescenceL E Kuil, R H van Scheppingen, Y M Leter, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1991

Phase I study of vintriptol, a tryptophan ester of vinblastineH M Oosterkamp, L T Vlasveld, J Wanders, et al.

Anti-Cancer Drugs|December 29, 2000

Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol) and carboplatin in non-small cell lung cancer patientsJ Meerum Terwogt, O van Tellingen, V R Nannan Panday, et al.

European Journal of Cancer (Oxford, England : 1990)|June 13, 1998

Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell linesP J van de Vaart, N van der Vange, F A Zoetmulder, et al.

Cell|May 20, 1994

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsA H Schinkel, J J Smit, O van Tellingen, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteinsA H Schinkel, U Mayer, E Wagenaar, et al.

The Journal of Pharmacology and Experimental Therapeutics|April 14, 2006

Carcinogen and anticancer drug transport by Mrp2 in vivo: studies using Mrp2 (Abcc2) knockout miceM L H Vlaming, K Mohrmann, E Wagenaar, et al.

Pageof 10